Endoscopic resection of early esophageal tumors in patients with cirrhosis or portal hypertension: a multicenter observational study

Abstract

Background Liver cirrhosis and esophageal cancer share several risk factors, such as alcohol intake and excess weight. Endoscopic resection is the gold standard treatment for superficial tumors. Portal hypertension and coagulopathy may increase the bleeding risk in these patients. This study aimed to assess the safety and efficacy of endoscopic resection for early esophageal neoplasia in patients with cirrhosis or portal hypertension.

Methods This retrospective multicenter international study included consecutive patients with cirrhosis or portal hypertension who underwent endoscopic resection in the esophagus from January 2005 to March 2021.

Results 134 lesions in 112 patients were treated, including by endoscopic submucosal dissection in 101 cases (75 %). Most lesions (128/134, 96 %) were in patients with liver cirrhosis, with esophageal varices in 71 procedures. To prevent bleeding, 7 patients received a transjugular intrahepatic portosystemic shunt, 8 underwent endoscopic band ligation (EBL) before resection, 15 received vasoactive drugs, 8 received platelet transfusion, and 9 underwent EBL during the resection procedure. Rates of complete macroscopic resection, en bloc resection, and curative resection were 92 %, 86 %, and 63 %, respectively. Adverse events included 3 perforations, 8 delayed bleedings, 8 sepsis, 6 cirrhosis decompensations within 30 days, and 22 esophageal strictures; none required surgery. In univariate analysis, cap-assisted endoscopic mucosal resection was associated with delayed bleeding (P = 0.01).

Conclusions In patients with liver cirrhosis or portal hypertension, endoscopic resection of early esophageal neoplasia appeared to be effective and should be considered in expert centers with choice of resection technique, following European Society of Gastrointestinal Endoscopy guidelines to avoid undertreatment.

Publication History

Received: 03 April 2022

Accepted after revision: 03 May 2023

Accepted Manuscript online:
03 May 2023

Article published online:
13 July 2023

• References

• 1 Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol 2013; 19: 5598-5606
• 2 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – update 2022. Endoscopy 2022; 54: 591-622
• 3 Miaglia C, Guillaud O, Rivory J. et al. Safe and effective digestive endoscopic resection in patients with cirrhosis: a single-center experience. Endoscopy 2020; 52: 276-284
• 4 Inoue H, Endo M, Takeshita K. et al. Endoscopic resection of carcinoma in situ of the esophagus accompanied by esophageal varices. Surg Endosc 1991; 5: 182-184
• 5 Funakoshi K, Akiyama N, Kozakai I. et al. Successful endoscopic therapy of superficial esophageal cancer on varices in a patient with alcoholic liver cirrhosis. Dig Endosc 2001; 13: 212-215
• 6 Ciocîrlan M, Chemali M, Lapalus MG. et al. Esophageal varices and early esophageal cancer: can we perform endoscopic mucosal resection (EMR)?. Endoscopy 2008; 40 (Suppl. 02) E91
• 7 Tsou YK, Liu CY, Fu KI. et al. Endoscopic submucosal dissection of superficial esophageal neoplasms is feasible and not riskier for patients with liver cirrhosis. Dig Dis Sci 2016; 61: 3565-3571
• 8 Shiratori Y, Ikeya T, Nakamura K. Early esophageal squamous cell carcinoma on varix treated with endoscopic submucosal dissection after variceal banding. ACG Case Rep J 2019; 6: e00185
• 9 Künzli HT, Weusten BLAM. Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: how to succeed while preventing the bleed. Endoscopy 2014; 46: 631-632
• 10 Xu ZG. Novel endoscopic treatment strategy for early esophageal cancer in cirrhotic patients with esophageal varices. Oncol Lett 2019; 18: 2560-2567
• 11 de Franchis R, Bosch J, Garcia-Tsao G. et al. Baveno VII – renewing consensus in portal hypertension. J Hepatol 2022; 76: 959-974
• 12 Veitch AM, Vanbiervliet G, Gershlick AH. et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy 2016; 48: c1
• 13 Japan Esophageal Society. Japanese classification of esophageal cancer, 11th Edition: part I. Esophagus 2017; 14: 1-36
• 14 Lauby-Secretan B, Scoccianti C, Loomis D. et al. Body fatness and cancer – viewpoint of the IARC Working Group. N Engl J Med 2016; 375: 794-798
• 15 Trivin F, Boucher E, Vauléon E. et al. Management of esophageal carcinoma associated with cirrhosis: a retrospective case–control analysis. J Oncol 2009; 2009: 173421
• 16 Repici A, Pagano N, Hassan C. et al. Endoscopic submucosal dissection of gastric neoplastic lesions in patients with liver cirrhosis: a systematic review. J Gastrointest Liver Dis 2012; 21: 303-307
• 17 Kato M, Nishida T, Hamasaki T. et al. Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis. Surg Endosc 2015; 29: 1560-1566
• 18 Fares N, Robic M-A, Péron J-M. et al. Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study. Eur J Gastroenterol Hepatol 2018; 30: 21-26
• 19 Schmitz A, Haste P, Johnson MS. Transjugular intrahepatic portosystemic shunt (TIPS) creation prior to abdominal operation: a retrospective analysis. J Gastrointest Surg 2020; 24: 2228-2232
• 20 Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol 2013; 19: 1424-1437
• 21 Wan S-Z, Nie Y, Zhang Y. et al. Assessing the prognostic performance of the Child–Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in patients with decompensated cirrhosis: a large Asian cohort from gastroenterology department. Dis Markers 2020; 2020: 5193028
• 22 Pimentel-Nunes P, Ribeiro D, Ponchon T. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. 2015; 47: 829-854
• 23 Terheggen G, Horn EM, Vieth M. et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia. Gut 2017; 66: 783
• 24 Ishihara R, Iishi H, Uedo N. et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008; 68: 1066-1072
• 25 Takahashi H, Arimura Y, Masao H. et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010; 72: 255-264
• 26 de Goede B, Klitsie PJ, Lange JF. et al. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis; a systematic review. Best Pract Res Clin Gastroenterol 2012; 26: 47-59
• 27 Starczewska MH, Mon W, Shirley P. Anaesthesia in patients with liver disease. Curr Opinion Anesthesiol 2017; 30: 392-398
• 28 Ono S, Fujishiro M, Niimi K. et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 2009; 70: 860-866
• 29 Kawaguchi G, Sasamoto R, Abe E. et al. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiation Oncology 2015; 10: 31
• 30 Ishihara R. Prevention of esophageal stricture after endoscopic resection. Dig Endosc 2019; 31: 134-145
• 31 Takahashi H, Arimura Y, Okahara S. et al. A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection. BMC Gastroenterol 2015; 15: 1
• 32 Irvine KM, Ratnasekera I, Powell EE. et al. Causes and consequences of innate immune dysfunction in cirrhosis. Front Immunol 2019; 10: 293